RE-BVS – Piemonte Repository

Sfoglia per AUTORE
MARGIOTTA-CASALUCI G
Collezione AOU Novara

Items : 6

Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study. in Annals of hematology / Ann Hematol. 2025 Mar;104(3):1655-1667. doi: 10.1007/s00277-025-06295-0. Epub 2025 Mar 12.

2025
AO Cuneo
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AOU Novara

Massaia M; Castellino C; Galimberti S; Rattotti S; Annibali O; Conconi A; Margiotta-Casaluci G; Farina L; Meli E; Anastasia A; Bozzoli V; Mecacci B; Bigliardi S; Merli M; Cocito F; Marchesi F; Fanelli F; Perrone T; Clerico M; Nicoli P; Vanazzi A; Boccomini C; Comba L; Bertolotti L; Castellino A;

Correction to: Anti CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the RFolSTOP multicentre Italian study. in Annals of hematology / Ann Hematol. 2025 Apr;104(4):2579-2580. doi: 10.1007/s00277-025-06369-z.

2025
AOU Novara

Castellino A; Comba L; Bertolotti L; Boccomini C; Clerico M; Nicoli P; Vanazzi A; Fanelli F; Perrone T; Marchesi F; Cocito F; Merli M; Bigliardi S; Mecacci B; Bozzoli V; Margiotta-Casaluci G; Meli E; Anastasia A; Farina L; Annibali O; Conconi A; Rattotti S; Galimberti S; Castellino C; Massaia M;

Effects of daratumumab on hematopoietic stem cell collection and engraftment in multiple myeloma patients eligible for autologous transplantation: results of the real-life PRIMULA study comparing bortezomib, thalidomide and dexamethasone (VTd) with VTd plus daratumumab (D-VTd) as induction therapy. in Annals of hematology / Ann Hematol. 2024 Oct;103(10):4345-4347. doi: 10.1007/s00277-024-05933-3. Epub 2024 Aug 22.

2024
AOU Novara

Strafella V; Attolico I; Carluccio P; Tarantini F; Curci P; Sgherza N; Rizzi R; Ostuni A; Buda G; Del Giudice ML; Marasco V; Mele A; Margiotta-Casaluci G; Valli VB; Mele G; Germano CR; Quinto AM; Palazzo G; Febbo MA; Ciuffreda L; Reddiconto G; Di Renzo N; Cimminiello M; Albano F; Musto P;

New Frontiers in Monoclonal Antibodies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma. in Cancers / Cancers (Basel). 2023 Dec 30;16(1):187. doi: 10.3390/cancers16010187.

2023
AOU Novara

Schipani M; Rivolta GM; Margiotta-Casaluci G; Mahmoud AM; Al Essa W; Gaidano G; Bruna R;

Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi. in Frontiers in oncology / Front Oncol. 2023 Mar 10;13:1120967. doi: 10.3389/fonc.2023.1120967. eCollection 2023.

2023
AO Cuneo
AOU Città della Salute di Torino
AOU Novara

Fama A; Olivieri J; Zaja F; Rotondo F; Kovalchuk S; Cattina F; Cenfra N; Ciavarella S; Castellino A; Bozzoli V; Boccomini C; Annibali O; Nicolosi M; Petrucci L; Meli E; Cocito F; Bigliardi S; Margiotta-Casaluci G;

Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. in Hematological oncology / Hematol Oncol. 2018 Dec;36(5):757-764. doi: 10.1002/hon.2536. Epub 2018 Aug 16.

2018
AOU Novara

Conconi A; Zucca E; Margiotta-Casaluci G; Darling K; Hasse B; Battegay M; Staehelin C; Novak U; Schmid P; Scherrer A; Dirnhofer S; Kwee I; Nassi L; Cavalli F; Gaidano G; Bertoni F; Bernasconi E;